Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers.
João LoboAd J M GillisAnnette van den BergLeendert H J LooijengaPublished in: BMC cancer (2020)
The informative protein biomarkers (i.e., MIB-1, CXCL12, beta-catenin, and possibly CXCR4) may prove useful for risk-stratifying patients if validated in larger, multicentric and well-defined studies. Currently, classical histopathological features of testicular germ cell tumors remain key for relapse prediction.